Abstract CT224: mRNA-4157, a personalized cancer vaccine, in combination with pembrolizumab, demonstrates trend for improved recurrence free survival compared to pembrolizumab alone in adjuvant…

Overview of attention for article published in Cancer Research, May 2023

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (85th percentile)
Good Attention Score compared to outputs of the same age and source (73rd percentile)

So far, Altmetric has seen 2 news stories from 2 outlets.

Published: Nov 20, 2023 By Sruthi S. Balakrishnan BioSpace Several cancer vaccine candidates are flying through clinical trials…

Pictured: Vaccine bottles/iStock, May Lim Several cancer vaccine candidates are flying through clinical trials with promising…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.